Erythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy
- PMID: 14965482
Erythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy
Comment on
-
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.Lancet. 2003 Oct 18;362(9392):1255-60. doi: 10.1016/S0140-6736(03)14567-9. Lancet. 2003. PMID: 14575968 Clinical Trial.